Paper17954373
Integrins: molecular determinants of glioma invasion.
D'Abaco GM and 1 other. J Clin Neurosci, 2007. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Integrins: molecular determinants of glioma invasion. Papers, record 17954373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17954373
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Glioma | Major topic |
| Integrins | Major topic |
| Humans | |
| Neoplasm Invasiveness |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41595739 | The Extracellular Matrix, the Silent 'Architect' of Glioma. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595739 | PubMed |
| 41210309 | Diamond Nanoparticles Suppress Migration of T98G Glioblastoma Cells by Targeting ECM-Integrin Interactions and Intracellular Signaling, Leading to Extensive Proteome Alterations. | Nanotechnol Sci Appl | 2025 | https://conductscience.org/library/papers/41210309 | PubMed |
| 40863857 | Dynamic Susceptibility Contrast Magnetic Resonance Imaging with Carbon-Encapsulated Iron Nanoparticles Navigated to Integrin Alfa V Beta 3 Receptors in Rat Glioma. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/40863857 | PubMed |
| 40585979 | Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies. | Theranostics | 2025 | https://conductscience.org/library/papers/40585979 | PubMed |
| 40512281 | Clinical utility of GAL-8, ITGΒ-1, and HIF-1α as non-invasive diagnostic and prognostic biomarkers for assessing glioma. | J Neurooncol | 2025 | https://conductscience.org/library/papers/40512281 | PubMed |
| 40321805 | Carbon-Encapsulated Iron Nanoparticles Seeking Integrins in Murine Glioma. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40321805 | PubMed |
| 39972389 | Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/39972389 | PubMed |
| 39876060 | Extension of T2 Hyperintense Areas in Patients With a Glioma: A Comparison Between High-Quality 7 T MRI and Clinical Scans. | NMR Biomed | 2025 | https://conductscience.org/library/papers/39876060 | PubMed |
| 39866225 | EMP2 promotes hepatocellular carcinoma proliferation and invasion by activating cellular autophagy. | Oncol Res | 2025 | https://conductscience.org/library/papers/39866225 | PubMed |
| 39595920 | Prognostic Role of Invasion-Related Extracellular Matrix Molecules in Diffusely Infiltrating Grade 2 and 3 Astrocytomas. | Brain Sci | 2024 | https://conductscience.org/library/papers/39595920 | PubMed |
| 37835499 | Effect of Dimeric Disintegrins Isolated from Vipera lebetina obtusa Venom on Glioblastoma Cellular Responses. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37835499 | PubMed |
| 36187469 | Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/36187469 | PubMed |
| 35631639 | Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future? | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35631639 | PubMed |
| 35527815 | Separating Glioma Hyperintensities From White Matter by Diffusion-Weighted Imaging With Spherical Tensor Encoding. | Front Neurosci | 2022 | https://conductscience.org/library/papers/35527815 | PubMed |
| 34771696 | Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771696 | PubMed |
| 34067658 | The Multifunctional Role of EMP3 in the Regulation of Membrane Receptors Associated with IDH-Wild-Type Glioblastoma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34067658 | PubMed |
| 33966944 | Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy. | Z Med Phys | 2022 | https://conductscience.org/library/papers/33966944 | PubMed |
| 33807786 | Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33807786 | PubMed |
| 32490210 | Gene expression of Epithelial Membrane Protein 2 gene and β1-Integrin gene in patients with breast cancer. | Biochem Biophys Rep | 2020 | https://conductscience.org/library/papers/32490210 | PubMed |
| 31986121 | Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/31986121 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17954373
GET https://conductscience.org/api/papers/v1/17954373/cited_by?page=2